Cargando…

Post-marketing reports of pancreatitis in eluxadoline-treated patients pre and post US label change

BACKGROUND: Eluxadoline, a United States Food and Drug Administration (FDA)-approved treatment for irritable bowel syndrome with diarrhea (IBS-D), underwent a change to its US prescribing information on 21 April 2017, contraindicating it in patients without a gallbladder due to increased risk of pan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cash, Brooks D., Lacy, Brian E., Watton, Cheryl, Schoenfeld, Philip S., Weissman, Darren
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8042552/ https://www.ncbi.nlm.nih.gov/pubmed/33953798 http://dx.doi.org/10.1177/17562848211001725

Ejemplares similares

Safety of Eluxadoline in Patients with Irritable Bowel Syndrome with Diarrhea
por: Cash, Brooks D, et al.
Publicado: (2017)

Eluxadoline Efficacy in IBS-D Patients Who Report Prior Loperamide Use
por: Lacy, Brian E, et al.
Publicado: (2017)

An Open‐Label Study to Evaluate the Effect of Eluxadoline on the Single‐Dose Pharmacokinetics of Midazolam in Healthy Participants
por: Boinpally, Ramesh, et al.
Publicado: (2022)

Single‐dose Pharmacokinetics of Eluxadoline in Healthy Participants With Normal Renal Function and Participants With Renal Impairment
por: Boinpally, Ramesh, et al.
Publicado: (2022)

Effect of Hepatic Impairment on Eluxadoline Pharmacokinetics
por: Marbury, Thomas C., et al.
Publicado: (2017)

Evaluation of Eluxadoline Effect on Cardiac Repolarization
por: Bonifacio, Laura, et al.
Publicado: (2018)

Efficacy and Safety of Eluxadoline in Patients With Irritable Bowel Syndrome With Diarrhea Who Report Inadequate Symptom Control With Loperamide: RELIEF Phase 4 Study
por: Brenner, Darren M., et al.
Publicado: (2019)

Effects of treatment with eluxadoline on abdominal pain in patients with IBS‐D: Additional post hoc analyses of Phase 3 trials
por: Lembo, Anthony J., et al.
Publicado: (2020)

Eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome
por: Özdener, Ayşe Elif, et al.
Publicado: (2017)

Post‐marketing dosing changes in the label of biologicals
por: Minnema, Lotte A., et al.
Publicado: (2019)

Spotlight on eluxadoline for the treatment of patients with irritable bowel syndrome with diarrhea
por: Fragkos, Konstantinos C
Publicado: (2017)

Impact of patient and disease characteristics on the efficacy and safety of eluxadoline for IBS-D: a subgroup analysis of phase III trials
por: Lacy, Brian E., et al.
Publicado: (2019)

Clinical potential of eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome
por: Sobolewska-Włodarczyk, Aleksandra, et al.
Publicado: (2016)

Eluxadoline-induced Recurrent Pancreatitis in a Young Female without a Gallbladder: A Case Report and Literature Review
por: Khetpal, Neelam, et al.
Publicado: (2018)

Market capitalization: Pre and post COVID-19 analysis
por: Praveen Kumar, M., et al.
Publicado: (2021)

Update on Eluxadoline for the Treatment of Irritable Bowel Syndrome with Diarrhea: Patient Selection and Perspectives
por: Liu, Rebecca, et al.
Publicado: (2020)

In Silico Food-Drug Interaction: A Case Study of Eluxadoline and Fatty Meal
por: Maruca, Annalisa, et al.
Publicado: (2020)

2489. Adverse Events with Biktarvy: Post-Marketing Study
por: Hayes, Edwin, et al.
Publicado: (2019)

Analyzing the U.S. Post-marketing safety surveillance of COVID-19 vaccines
por: Albalawi, Omar M., et al.
Publicado: (2022)

Pre- and post-pandemic seafood purchasing behavior in the U.S.
por: Engle, Carole, et al.
Publicado: (2023)

Molecular characterization of eluxadoline as a potential ligand targeting mu-delta opioid receptor heteromers
por: Fujita, Wakako, et al.
Publicado: (2014)

Eluxadoline Loaded Solid Lipid Nanoparticles for Improved Colon Targeting in Rat Model of Ulcerative Colitis
por: Anwer, Md. Khalid, et al.
Publicado: (2020)

Solvent/Detergent-Treated Plasma in the Management of Pediatric Patients Who Require Replacement of Multiple Coagulation Factors: An Open-Label, Multicenter, Post-marketing Study
por: Spinella, Philip C., et al.
Publicado: (2020)

Improved work productivity and health-related quality of life in patients with irritable bowel syndrome with diarrhea receiving eluxadoline following inadequate response to loperamide
por: Brenner, Darren M, et al.
Publicado: (2021)

What the stock market tells us about the post-COVID-19 world
por: Wagner, Alexander F.
Publicado: (2020)

Eluxadoline Versus Antispasmodics in the Treatment of Irritable Bowel Syndrome: An Adjusted Indirect Treatment Comparison Meta-analysis
por: Qin, Di, et al.
Publicado: (2022)

Ethics and the marketing authorization of pharmaceuticals: what happens to ethical issues discovered post-trial and pre-marketing authorization?
por: Bernabe, Rosemarie D. L. C., et al.
Publicado: (2020)

The impact of treatment with eluxadoline on health-related quality of life among adult patients with irritable bowel syndrome with diarrhea
por: Abel, Jessica L., et al.
Publicado: (2018)

Best practices for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis
por: Weissman, Simcha, et al.
Publicado: (2021)

Applications of gravity models to evaluate and forecast US international air freight markets post-GFC()
por: Alexander, D.W., et al.
Publicado: (2021)

Effect of uptake transporters OAT3 and OATP1B1 and efflux transporter MRP2 on the pharmacokinetics of eluxadoline
por: Davenport, J Michael, et al.
Publicado: (2015)

Preparation, Evaluation and Bioavailability Studies of Eudragit Coated PLGA Nanoparticles for Sustained Release of Eluxadoline for the Treatment of Irritable Bowel Syndrome
por: Anwer, Md. K., et al.
Publicado: (2017)

Potency and Therapeutic THC and CBD Ratios: U.S. Cannabis Markets Overshoot
por: Pennypacker, Sarah D., et al.
Publicado: (2022)

Pre- versus post-exercise protein intake has similar effects on muscular adaptations
por: Schoenfeld, Brad Jon, et al.
Publicado: (2017)

To Post or Not to Post: Plastic Surgery Practice Marketing, Websites, and Social Media?
por: Mess, Sarah A., et al.
Publicado: (2019)

COVID-19, jobs and skills—Exploratory analysis of the job postings in the US and UK healthcare job market
por: Upadhyay, Himanshu, et al.
Publicado: (2023)

Early response predicts a sustained response to eluxadoline in patients with irritable bowel syndrome with diarrhoea in two Phase 3 studies
por: Chey, W. D., et al.
Publicado: (2017)

Correction: Pre- versus post-exercise protein intake has similar effects on muscular adaptations
por: Schoenfeld, Brad Jon, et al.
Publicado: (2017)

An Open-Label, Multicentre, Observational, Post-Marketing Study to Monitor the Safety and Effectiveness of Umeclidinium/Vilanterol in Korean Patients
por: Cho, Eun-Yeong, et al.
Publicado: (2023)

TV advertising and dietary intake in adolescents: a pre- and post- study of Chile’s Food Marketing Policy
por: Jensen, Melissa L., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s1vtbgrdl7lpsrfi6k1lccetds